Livermore

Cadrenal Therapeutics, Inc.

CVKD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001937993

Insider trades, last 90 days

0 buys · 1 sell

  • Sold $22.42K
  • Open-market purchases (P) and sales (S), counted by Form 4 filing.
View insider trades

13F holders, Q2 2026

19

  • −1 vs. Q1 2026
  • Total value $379.76K
View 13F holders

Superinvestors holding CVKD

0

  • None of the superinvestors held CVKD at the end of Q2 2026.
See all holders

Price chart

Latest insider trades

View all: Latest insider trades

Open-market purchases and sales by CVKD insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Jul 1, 20269:52 PM ETJun 29, 2026Pham Quang XChairman and CEOSSaleCommon Stock−7.4K$3.03−$22.42K98.59K−7.0%SEC10b5-1
Jun 26, 2026Jun 25 – Jun 26, 2026Pham Quang XChairman, CEO and Interim CFOSSaleCommon Stock−11.16K$3.0405−$33.92K105.99K−9.5%SEC10b5-1
Jun 24, 2026Jun 22 – Jun 23, 2026Pham Quang XChairman, CEO and Interim CFOSSaleCommon Stock−11.44K$3.4804−$39.83K117.15K−8.9%SEC10b5-1
Jun 18, 2026Jun 16 – Jun 17, 2026Pham Quang XChairman, CEO and Interim CFOSSaleCommon Stock−4.13K$3.1775−$13.11K128.59K−3.1%SEC10b5-1
Jun 15, 2026Jun 11 – Jun 15, 2026Pham Quang XChairman, CEO and Interim CFOSSaleCommon Stock−18.12K$3.8817−$70.35K132.72K−12.0%SEC

Top 5 13F holders, Q2 2026

View all: Top 5 13F holders, Q2 2026

The largest institutional positions in CVKD at the end of Q2 2026.

Institutions holding CVKD in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
VANGUARD CAPITAL MANAGEMENT LLC50,137$167.46K0.00%+4,936+10.9%Added
HRT FINANCIAL LP29,055$97K0.00%+29,055New
GEODE CAPITAL MANAGEMENT, LLC19,024$63.54K0.00%−2,602−12.0%Reduced
VANGUARD FIDUCIARY TRUST CO8,311$27.76K0.00%00.0%Unchanged
CoreCap Advisors, LLC1,285$4.29K0.00%+1,285New